BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10969815)

  • 1. Evaluation of microsatellite analysis in urine sediment for diagnosis of bladder cancer.
    Schneider A; Borgnat S; Lang H; Régine O; Lindner V; Kassem M; Saussine C; Oudet P; Jacqmin D; Gaub MP
    Cancer Res; 2000 Aug; 60(16):4617-22. PubMed ID: 10969815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
    Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput molecular analysis of urine sediment for the detection of bladder cancer by high-density single-nucleotide polymorphism array.
    Hoque MO; Lee J; Begum S; Yamashita K; Engles JM; Schoenberg M; Westra WH; Sidransky D
    Cancer Res; 2003 Sep; 63(18):5723-6. PubMed ID: 14522891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic deletion fingerprinting of urine cell sediments in bladder cancer.
    Larsson PC; Beheshti B; Sampson HA; Jewett MA; Shipman R
    Mol Diagn; 2001 Sep; 6(3):181-8. PubMed ID: 11571711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of bladder cancer by semi-automated microsatellite analysis of urine sediment.
    Baron A; Mastroeni F; Moore PS; Bonetti F; Orlandini S; Manfrin E; Schiavone D; Migliorini F; Lusuardi L; Mobilio G; Scarpa A
    Adv Clin Path; 2000 Jan; 4(1):19-24. PubMed ID: 10936895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment.
    Szarvas T; Kovalszky I; Bedi K; Szendroi A; Majoros A; Riesz P; Füle T; László V; Kiss A; Romics I
    Oncol Rep; 2007 Aug; 18(2):405-9. PubMed ID: 17611663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of genetic abnormalities and telomerase expression in exfoliated urinary cells for bladder cancer detection.
    Neves M; Ciofu C; Larousserie F; Fleury J; Sibony M; Flahault A; Soubrier F; Gattegno B
    J Urol; 2002 Mar; 167(3):1276-81. PubMed ID: 11832713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsatellite analysis of urine sediment versus urine cytology for diagnosing transitional cell tumors of the urinary bladder.
    Fornari D; Steven K; Hansen AB; Vibits H; Jepsen JV; Poulsen AL; Schwartz M; Horn T
    APMIS; 2004 Feb; 112(2):148-52. PubMed ID: 15056232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic instability analysis of urine sediment versus tumor tissue in transitional cell carcinoma of the urinary bladder.
    Turyn J; Matuszewski M; Schlichtholz B
    Oncol Rep; 2006 Jan; 15(1):259-65. PubMed ID: 16328066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular urinary sediment analysis in patients with transitional cell bladder carcinoma.
    Dal Canto M; Bartoletti R; Travaglini F; Piazzini M; Lodovichi G; Rizzo M; Selli C
    Anticancer Res; 2003; 23(6D):5095-100. PubMed ID: 14981972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplex polymerase chain reaction for microsatellite analysis of urine sediment cells: a rapid and inexpensive method for diagnosing and monitoring superficial transitional bladder cell carcinoma.
    Bartoletti R; Cai T; Dal Canto M; Boddi V; Nesi G; Piazzini M
    J Urol; 2006 Jun; 175(6):2032-7; discussion 2037. PubMed ID: 16697794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite analysis of free tumor DNA in urine, serum, and plasma of patients: a minimally invasive method for the detection of bladder cancer.
    Utting M; Werner W; Dahse R; Schubert J; Junker K
    Clin Cancer Res; 2002 Jan; 8(1):35-40. PubMed ID: 11801538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A further study on potential of microsatellite analysis of urine in diagnosis of bladder cancer].
    Zhang J; Zheng S; Di X
    Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(20):1224-6. PubMed ID: 11825522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
    Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D
    J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of urinary microsatellite analysis in the diagnosis of renal cancer].
    Fernandez F; Schneider A; Gaub MP; Lindner V; Oudet P; Lang H; Saussine C; Jacqmin D
    Prog Urol; 2006 Sep; 16(4):429-34. PubMed ID: 17069034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradient gel electrophoresis urinalysis.
    Curigliano G; Ferretti G; Flamini G; Goldhirsch A; de Braud F; Calabro MG; Mandaly M; Nole F; De Pas T; D'Addessi A; Cittadini A
    Anticancer Res; 2001; 21(4B):3015-20. PubMed ID: 11712804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic detection of bladder cancer by microsatellite analysis of p16, RB1 and p53 tumor suppressor genes.
    Sourvinos G; Kazanis I; Delakas D; Cranidis A; Spandidos DA
    J Urol; 2001 Jan; 165(1):249-52. PubMed ID: 11125419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite analysis of voided-urine samples for surveillance of low-grade non-muscle-invasive urothelial carcinoma: feasibility and clinical utility in a prospective multicenter study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer trial [CEFUB]).
    van der Aa MN; Zwarthoff EC; Steyerberg EW; Boogaard MW; Nijsen Y; van der Keur KA; van Exsel AJ; Kirkels WJ; Bangma C; van der Kwast TH
    Eur Urol; 2009 Mar; 55(3):659-67. PubMed ID: 18501499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis.
    Rouprêt M; Hupertan V; Yates DR; Comperat E; Catto JW; Meuth M; Lackmichi A; Ricci S; Lacave R; Gattegno B; Richard F; Hamdy FC; Cussenot O
    BJU Int; 2008 Jun; 101(11):1448-53. PubMed ID: 18325051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
    Kumar A; Kumar R; Gupta NP
    Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.